Company / Gross Profit
CLOVER HEALTH INVESTMENTS, CORP. /DE Gross Profit History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$257.3M
FY2023
5-year range
-$79.2M / $257.3M
FY2021-FY2023
Trend
+1031.9%
vs FY2022
Sector context
#76 of 100
Health Care
What the data says
Gross Profit changed +1032% YoY in FY2023, a notable deviation from the 2-year average annual change of +580%.
Based on SEC 10-K filings.
$257M in FY2023.
Improved from -$79M to $257M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 100This company $257.3M Sector average $1.8B
▼
-85.8% below sector average
Key checks
Key Insights
- In FY2023, gross profit increased 1031.9% year-over-year.
- Ranks #76 out of 100 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $257.3M | +1031.9% |
| FY2022 | $22.7M | +128.7% |
| FY2021 | -$79.2M | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026